Deep dive into muscle repair yields new strategies to combat Duchenne muscular dystrophy

Researchers at the Sanford Burnham Prebys Medical Discovery Institute (SBP) reported new findings this week that may lead to novel therapeutic strategies for people suffering from Duchenne muscular dystrophy (DMD). DMD, a muscle-wasting disease that affects 1 in 7250 males aged 5 to 24 years in the United States, is caused by a genetic mutation leading…

Frontiers Current Pharmacological Strategies for Duchenne Muscular Dystrophy

muscle stem cells, The Stem Cellar

Muscle and cardiac therapeutic strategies for Duchenne muscular dystrophy: past, present, and future

Dystrophin Expressing Chimeric (DEC) Cell Therapy for Duchenne Muscular Dystrophy: A First-in-Human Study with Minimum 6 Months Follow-up

Vascular-targeted therapies for Duchenne muscular dystrophy, Skeletal Muscle

CRISPR Clinical Trials: A 2023 Update - Innovative Genomics

Recent advances in the management of Duchenne muscular dystrophy

Bold New Therapy Delivery Method Shows Initial Promise as Treatment for Duchenne Muscular Dystrophy - Research Horizons

Proteomes, Free Full-Text

Eteplirsen in the treatment of Duchenne muscular dystrophy

Muscular Dystrophy Treatment in India

Maximizing Muscle Recovery: The Role of Post-Workout Nutrition

JCM, Free Full-Text

Protein discovery promises powerful new muscle regrowth treatments

How likely is a muscle repair to rupture and would you know about it?

Bioengineering, Free Full-Text